FindTrial
Sign In

68GA-NOTA-E(PEG4-TMVP1)2 PET/CT in the diagnosis of cervical cancer, ovarian cancer, breast cancer and lung cancer

the value of 68GA-NOTA-E(PEG4-TMVP1)2 PET/CT in patients with cervical cancer, ovarian cancer, breast cancer and lung cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DOD-17012458
Enrollment
Unknown
Registered
2017-08-23
Start date
2017-09-01
Completion date
Unknown
Last updated
2017-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer, Cervical Cancer, Breast Cancer and Lung Cancer

Interventions

Staining
Gold Standard:Pathological examination
Index test:VEGFR-3&#32
Immunohistochemistry&#32

Sponsors

Department of Nuclear Medicine, Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Female; Aged 20 to 70 years; The patients were suspected with Ovarian Cancer, Cervical Cancer, Breast Cancer and Lung Cancer.

Exclusion criteria

Exclusion criteria: Pregancy or nursing patients; Heptic or renal insufficiency patients; The patients with severe conditon.

Design outcomes

Primary

MeasureTime frame
sensitivity;accuracy;—

Countries

China

Contacts

Public ContactFang Li

PUMC Hospital

lifang@pumch.cn+86 10 65295502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026